Disc Medicine (IRON) Operating Leases (2021 - 2026)

Disc Medicine (IRON) has 6 years of Operating Leases data on file, last reported at $1.3 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $1.3 million, down 21.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 21.85% YoY), and the FY2025 annual result was $1.3 million, down 19.06% from the prior year.
• Operating Leases advanced to $1.3 million in Q1 2026 per IRON's latest filing, from $1.3 million in the prior quarter.
• Over five years, Operating Leases peaked at $1.8 million in Q2 2023 and troughed at $945000.0 in Q1 2023.
• A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2024 and 2025: Operating Leases sank 39.16% in 2024, then soared 44.06% in 2025.
• A 5-year view of Operating Leases shows it stood at $1.0 million in 2022, then surged by 39.82% to $1.4 million in 2023, then rose by 7.8% to $1.5 million in 2024, then declined by 19.06% to $1.3 million in 2025, then rose by 1.92% to $1.3 million in 2026.
• Business Quant data shows IRON's Operating Leases at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.